§ Mr. BarronTo ask the Secretary of State for Health how many companies within the pharmaceutical price regulation scheme received each rate of return; how many exceeded their targets; and how many failed to reach their targets for each of the last three years for which figures are available. [34764]
§ Mr. MaloneThis information is not available for reasons of commercial confidentiality. The Department last month published a first report to Parliament on the pharmaceutical price regulation scheme, which provides an overall assessment of the operation of the scheme. Copies of the report are available in the Library.